Home

Close Ad ☒

Show Ad

A Consistent Standard for Dust Safety
The adoption of the National Fire Protection Association’s unified standard for combustible dusts and particulate solids, NFPA 660, marks an important evolution in combustible dust safety. Rather than introducing an entirely new philosophy, NFPA 660 consolidates several legacy combustible dust standards into one comprehensive document, providing a consistent framework for evaluating combustible dust hazards across all industries. read more
From Shore to Shore
More than six decades after Hovione’s humble basement beginnings, the company is still betting on the value of being global. But today, that means something different. It’s not simply about having manufacturing sites around the world. It’s about making those sites work both together and independently. read more
Can OSD Handle the GLP-1 Appetite?
The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s. read more
Oral Solid Dose Regulatory Approval Update
CDER has approved 33 novel drugs so far, almost half of which are oral solid dose formulations. read more

Taiho Announces Positive Phase 3 Results for Oral MDS and Leukemia Drug
October 06, 2026
The drug is an orally-available combination of azacitidine (currently approved for subcutaneous administration) and cedazuridine. read more
SPI Pharma, Colorcon Announce Global OSD Partnership
October 02, 2026
Together the companies aim to increase market coverage, customer reach, and awareness of oral dosage formats, read more
Novo Licenses Hengrui Once-Weekly Obesity Pill in Potential $2.6B Deal
October 01, 2026
The phase 1-ready GLP-1/GIP dual receptor agonist has the potential to treat patients with obesity and type 2 diabetes. read more